ABSTRACT
The apoptotic effect of bacteria-derived beta-glucan was investigated in human colon cancer cells SNU-C4 using terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick end labeling (TUNEL) assay, reverse transcription-polymerase chain reaction (RT-PCR) expressions of Bcl-2, Bax, and Caspase-3 genes, and assay of caspase-3 enzyme activity. beta-Glucan of 10, 50, and 100 microg/mL decreased cell viability in a dose-dependent manner with typical apoptotic characteristics, such as morphological changes of chromatin condensation and apoptotic body formation from TUNEL assay. In addition, beta-glucan (100 microg/mL) decreased the expression of Bcl-2 by 0.6 times, whereas the expression of Bax and Caspase-3 were increased by 3.1 and 2.3 times, respectively, compared to untreated control group. Furthermore, the caspase-3 activity in the beta-glucan-treated group was significantly increased compared to those in control group (P < 0.05). Bacterial derived beta-glucan could be used as an effective compound inducing apoptosis in human colon cancer.
ABSTRACT
BACKGROUND: Although traditional Korean medicine (TKM) has been influenced by traditional Chinese medicine (TCM), it has developed distinctive features. Around the tenth century, Chinese medical books were introduced to Korea. In those days, Koreans started movement to develop its own medical system. METHODS: We reviewed Korean and Chinese medical literatures, and analysed the characteristics between two medical systems. RESULTS: In the early 17th century, Dongeuibogam was published by Dr Joon Hur. He provided a turning point to establish Korean medical system independent from TCM. TKM emphasizes specific characteristics of the individual who suffered from the disease, rather than single symptom. The concept was elaborated by Dr Jae Ma Lee who published Dongeuisusaebowon in the early 20th century. CONCLUSION: Through historical development, TKM has established the unique characteristic and modality as the whole-person-centered medicine.
